Company & Sponsor Intelligence

MedtronicNeuro

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →
Indexed trials7
Recruiting0
Completed5
Countries2

Therapeutic footprint

epilepsypain_neuropathyparkinsonsstroke

Indexed studies

NCT02844465Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate)
epilepsy · United States
NA
NCT00101933SANTE - Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy
epilepsy ·
PHASE3
NCT01098565Deep Brain Stimulation Effects Study
parkinsons · Germany
PHASE1
NCT01032239SISTERS: Spasticity In Stroke Study - Randomized Study
stroke · United States
PHASE4
NCT06499220Electrically Evoked Compound Action Potentials Human Observation Medtronic System Study (ECHO-MDT)
pain_neuropathy · United States
NA
NCT01850498Epilepsy Motion Sensing
epilepsy · United States
COMPLETED
NCT03446833LFP Beta aDBS Feasibility Study
parkinsons · United States
NA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →